Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TPLM-29-3

ABSTRACT: TPLM-29-3

SUBMITTER: Peng Xing

PROVIDER: OEX00023275 | NODE | 2024-06-11

REPOSITORIES: NODE

ACCESS DATA

Json Xml

Similar Datasets

TPLM-29-1

Project description:TPLM-29-1

2025-05-29 | OEX00023273 | NODE

TPLM-29-2

Project description:TPLM-29-2

2025-05-29 | OEX00023274 | NODE

<i>Aggregatibacter actinomycetemcomitans</i> Outer Membrane Proteins 29 and 29 Paralogue Induce Evasion of Immune Response.

Project description: Not available

| S-EPMC8851312 | biostudies-literature

DNase-seq from HT-29 (ENCSR814KRX).

Project description:DNase-seq on immortalized cell line HT-29, epithelial cells from a 44 year old female adult human colon with a colorectal adenocarcinoma. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2026-05-26 | GSE333112 | GEO

Affymetrix SNP array data for 29 MCL cases

Project description:DNA from four 29 cases, 38 tumor samples (23 PB, 12 LN, 1 Tonsil, 1 colonic biopsy, 1 spleen) and 29 normal DNA from the same patients were analyzed with Affymetrix SNP 6.0 platform for copy number alterations study. Affymetrix SNP arrays were performed according to the manufacturer's directions on DNA extracted from blood samples, lymph nodes and other tissues like spleen, tonsil and colonic biopsy

2013-11-04 | GSE46969 | GEO

HT-29 and SW620

Project description:This SuperSeries is composed of the SubSeries listed below.

2025-12-01 | GSE284658 | GEO

A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire.

Project description: Not available

| S-EPMC6660359 | biostudies-literature

29 untreated breast cancer cell lines vs. pool of all 29 cell lines.

Project description:Expression profiling of 29 untreated breast cancer cell lines using Agilent 4x44K V1 (G4112F) dual color oligonucleotide microarrays The primary study objective was to establish a research resource for comparative transcriptomic analysis of a series of commercially available breast cancer cell lines representative of diverse histopathologic and molecular subtypes, generated on the Agilent oligonucleotide platform. A specific study objective was to perform a comparative transcriptional analysis of three cell lines established from a patient with triple negative metaplastic inflammatory breast cancer developed by Drs. Felding Habermann and Smider at the Scripps Research Institute, San Diego, CA. Cancer Res 2011;71(24 Suppl):Abstract nr PD03-07.

2013-11-27 | GSE51086 | GEO

Abstracts from Rambam Research Day, December 29, 2011.

Project description: Not available

| S-EPMC3707411 | biostudies-literature

A Systematic Review of miR-29 in Cancer.

Project description: Not available

| S-EPMC6369137 | biostudies-literature